Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy
Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy
复制标题
新辅助化疗后胸腔镜食管切除术的可行性
DOI：
10.1111/j.1758-5910.2012.00131.x
复制
发表时间：
2012
影响因子：
1
通讯作者：
Y. Sakai
中科院分区：
文献类型：
--
作者：
E. Tanaka;H. Okabe;S. Tsunoda;K. Obama;T. Kan;Y. Kadokawa;M. Akagami;Y. Sakai
微创食管切除术已越来越被接受用于治疗食管癌。在日本，新辅助化疗加手术已成为晚期食管癌的标准手术。一项随机对照研究显示了新辅助化疗的生存获益，但化疗后微创食管切除术是否可行尚不清楚。本研究探讨了新辅助化疗后胸腔镜食管切除术的可行性。
Minimally invasive esophagectomy has been increasingly accepted to treat esophageal cancer. In Japan, neoadjuvant chemotherapy followed by surgery has become the standard procedure for advanced esophageal cancer. A randomized control study has shown neoadjuvant chemotherapy's survival benefits, but it is unknown whether minimally invasive esophagectomy after chemotherapy is viable. This study investigated the feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy.
影响因子：
158.5
作者：
Kelsen, DP;Ginsberg, R;Roth, JA
通讯作者：
Roth, JA